Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 2
2004 2
2005 2
2006 1
2007 2
2008 1
2010 1
2011 1
2012 2
2013 1
2014 1
2018 5
2019 1
2020 1
Text availability
Article attribute
Article type
Publication date

Search Results

20 results
Results by year
Filters applied: . Clear all
Page 1
The c-Abl inhibitor, Radotinib HCl, is neuroprotective in a preclinical Parkinson's disease mouse model.
Lee S, Kim S, Park YJ, Yun SP, Kwon SH, Kim D, Kim DY, Shin JS, Cho DJ, Lee GY, Ju HS, Yun HJ, Park JH, Kim WR, Jung EA, Lee S, Ko HS. Lee S, et al. Among authors: Shin JS. Hum Mol Genet. 2018 Jul 1;27(13):2344-2356. doi: 10.1093/hmg/ddy143. Hum Mol Genet. 2018. PMID: 29897434 Free PMC article.
Highly sensitive two-dimensional MoS2 gas sensor decorated with Pt nanoparticles.
Park J, Mun J, Shin JS, Kang SW. Park J, et al. R Soc Open Sci. 2018 Dec 12;5(12):181462. doi: 10.1098/rsos.181462. eCollection 2018 Dec. R Soc Open Sci. 2018. PMID: 30662750 Free PMC article.
Determination of a radotinib dosage regimen based on dose-response relationships for the treatment of newly diagnosed patients with chronic myeloid leukemia.
Noh H, Jung SY, Kwak JY, Kim SH, Oh SJ, Zang DY, Lee S, Park HL, Jo DJ, Shin JS, Do YR, Kim DW, Lee JI. Noh H, et al. Among authors: Shin JS. Cancer Med. 2018 May;7(5):1766-1773. doi: 10.1002/cam4.1436. Epub 2018 Mar 25. Cancer Med. 2018. PMID: 29577681 Free PMC article. Clinical Trial.
Mitigation Effects of a Novel Herbal Medicine, Hepad, on Neuroinflammation, Neuroapoptosis, and Neuro-Oxidation.
Song DH, Kim GJ, Lee KJ, Shin JS, Kim DH, Park BJ, An JH. Song DH, et al. Among authors: Shin JS. Molecules. 2018 Nov 8;23(11):2920. doi: 10.3390/molecules23112920. Molecules. 2018. PMID: 30413118 Free PMC article.
Pharmacokinetic drug interaction and safety after coadministration of clarithromycin, amoxicillin, and ilaprazole: a randomised, open-label, one-way crossover, two parallel sequences study.
Jin BH, Yoo BW, Park J, Kim JH, Lee JY, Shin JS, Park MS. Jin BH, et al. Among authors: Shin JS. Eur J Clin Pharmacol. 2018 Sep;74(9):1149-1157. doi: 10.1007/s00228-018-2489-2. Epub 2018 May 30. Eur J Clin Pharmacol. 2018. PMID: 29846770 Free PMC article. Clinical Trial.
Novel Small Molecule Targeting the Hemagglutinin Stalk of Influenza Viruses.
Kim JI, Lee S, Lee GY, Park S, Bae JY, Heo J, Kim HY, Woo SH, Lee HU, Ahn CA, Bang HJ, Ju HS, Ok K, Byun Y, Cho DJ, Shin JS, Kim DY, Park MS, Park MS. Kim JI, et al. Among authors: Shin JS. J Virol. 2019 Aug 13;93(17):e00878-19. doi: 10.1128/JVI.00878-19. Print 2019 Sep 1. J Virol. 2019. PMID: 31167918 Free PMC article.
Efficacy and safety of radotinib in chronic phase chronic myeloid leukemia patients with resistance or intolerance to BCR-ABL1 tyrosine kinase inhibitors.
Kim SH, Menon H, Jootar S, Saikia T, Kwak JY, Sohn SK, Park JS, Jeong SH, Kim HJ, Kim YK, Oh SJ, Kim H, Zang DY, Chung JS, Shin HJ, Do YR, Kim JA, Kim DY, Choi CW, Park S, Park HL, Lee GY, Cho DJ, Shin JS, Kim DW. Kim SH, et al. Among authors: Shin JS. Haematologica. 2014 Jul;99(7):1191-6. doi: 10.3324/haematol.2013.096776. Epub 2014 Apr 4. Haematologica. 2014. PMID: 24705186 Free PMC article. Clinical Trial.
Effect of CYP2C19 genetic polymorphism on pharmacokinetics and pharmacodynamics of a new proton pump inhibitor, ilaprazole.
Cho H, Choi MK, Cho DY, Yeo CW, Jeong HE, Shon JH, Lee JY, Shin JS, Cho M, Kim DY, Shin JG. Cho H, et al. J Clin Pharmacol. 2012 Jul;52(7):976-84. doi: 10.1177/0091270011408611. Epub 2011 May 18. J Clin Pharmacol. 2012. PMID: 21593280 Clinical Trial.
20 results
Jump to page